Schedule 13G ownership disclosure
Soleno Therapeutics Inc
Security class unavailable · CUSIP: 834203309
Event date: 2024-08-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-076217
- Form type
- SC 13G
- Filer
- SOLENO THERAPEUTICS INC
- CIK
- CIK 1484565
- Filed
- Sep 05, 2024
- Reporting period
- Aug 27, 2024
- Description
- Schedule 13G beneficial ownership